Biotechnology company BPC Instruments reported a decrease in revenue during the first quarter compared with the same period last year. Operating profit showed a loss compared with the previous period's profit.The final figures are in line with the preliminary figures previously published, as the company warned of weaker operating profit than expected.Revenue fell 3.8 percent to SEK 12.5 million (13).Operating profit was SEK -0.6 million (1). Profit after tax was SEK -0.5 million (0.3). Earnings per share amounted to SEK -0.04 (0.03)."The first quarter of 2026 was characterized by a cautious investment climate and longer decision-making processes among customers. Revenue and profit were below our expectations and EBIT was negative for the quarter. This result is obviously not satisfactory and we take it seriously. At the same time, the quarter should be viewed in light of timing, extended sales cycles, currency headwinds and continued investments in the platform and organization, not as a weakening of BPC's long-term market relevance," says CEO Jing Liu. BPC Instruments, SEK millionQ1-2026Q1-2025ChangeNet sales12.513-3.8%Operating profit-0.61Operating margin7.7%Net profit-0.50.3Earnings per share, SEK-0.040.03